Megan T. Sniecinski
Overview
Megan T. Sniecinski received an average of $4M in total compensation, including $323K in salary, at BioCryst Pharmaceuticals from 2019 to 2021.
Source: SEC filings on April 25, 2022 and March 31, 2020.
Related executives
We found 16 more executives who work or worked at BioCryst Pharmaceuticals.
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
Helen Thackray
BioCryst Pharmaceuticals
Chief R&D Officer
Anthony Doyle
BioCryst Pharmaceuticals
Chief Financial Officer
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
Yarlagadda Babu
BioCryst Pharmaceuticals
Chief Discovery Officer
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
Lynne Powell
BioCryst Pharmaceuticals
Senior Vice President and Chief Commercial Officer
Alane Barnes
BioCryst Pharmaceuticals